Female Sexual Dysfunction
Sexual concerns are common—and treatable. Hormonal shifts (PMS, perimenopause, post-menopause), medications, pelvic floor issues, pain conditions, and relationship or mental health factors can all contribute. A comprehensive history and medical evaluation help identify what’s driving symptoms and what options are most appropriate. [1][2]
Educational information only—your care plan is individualized.
What We Evaluate
Female sexual dysfunction (FSD) is multifactorial. Clinical organizations emphasize a biopsychosocial evaluation—looking at hormones, genitourinary symptoms, pain, pelvic floor health, medications, mood/stress, and relationship factors. [1][2]
Symptoms we commonly see
- Low desire or arousal concerns
- Orgasm difficulty
- Vaginal dryness, irritation, or burning
- Pain with intercourse (dyspareunia)
- Urinary urgency/leakage that impacts intimacy
Potential drivers
- Perimenopause/menopause and GSM (genitourinary syndrome of menopause) [3]
- Medications (including some antidepressants) [1]
- Pelvic floor dysfunction, vaginismus, vulvodynia [4][5]
- Prolapse or body-image concerns affecting confidence
- Stress, anxiety, depression, relationship factors [1]
Painful Intercourse
Pain with penetration can have many causes. Conditions such as vulvodynia and vaginismus are recognized contributors in some patients. Evaluation matters because treatment depends on the underlying cause (e.g., skin conditions, pelvic floor muscle tension, hormonal changes, infections). [4][5]
- We start with careful history + focused exam
- We consider pelvic floor and hormonal contributors
- We build a plan that prioritizes comfort and safety
Prolapse & Vaginal “Looseness” Concerns
Pelvic organ prolapse can affect comfort, confidence, and sexual wellbeing in some women. Your evaluation may include discussion of pelvic floor therapy, non-surgical supports, and surgical options when indicated. [6]
- Assessment of pelvic support + symptoms
- Discussion of conservative vs surgical approaches
- Shared decision-making based on goals and exam findings
Treatment Options
Treatment is individualized. In many cases, improving the underlying driver (hormonal, pain, pelvic floor, medication-related, or psychological) improves sexual function. Leading organizations emphasize that many effective treatments exist, and multidisciplinary care is often helpful. [1][2]
Hormone-related care
- Evaluation for GSM (dryness, irritation, urinary symptoms) [3]
- Evidence-based counseling on menopausal therapies (as appropriate) [3]
- Discussion of risks/benefits and medical contraindications
“Bioidentical hormones” should be discussed carefully; major societies caution against custom-compounded hormone therapy unless medically necessary. [3]
Pelvic floor + pain-focused care
- Pelvic floor physical therapy when indicated [2]
- Targeted treatment plans for vulvodynia/vaginismus [4][5]
- Lubricants/moisturizers and tissue-support strategies [3]
Device-based options (consult-driven)
- We discuss options like diVa with careful counseling on evidence and safety.
- The FDA has warned against marketing energy-based devices for “vaginal rejuvenation” claims and notes potential risks. [7]
Your consult determines appropriateness and alternatives.
Reconstructive / surgical options
- When indicated, reconstructive approaches may address structural concerns.
- We prioritize medical indication, function, and informed consent.
You deserve answers—and options.
Schedule a private consultation to identify likely causes and build a plan that supports comfort, confidence, and wellbeing.
FAQs
Is female sexual dysfunction common? +
Yes. Many women experience sexual concerns at some point, especially with hormonal transitions, stress, relationship factors, and medical conditions. Clinical resources emphasize that evaluation and treatment can help. [1][2]
What tests will I need? +
Testing depends on symptoms. Your clinician may recommend targeted hormonal or medical testing when indicated, along with a focused exam. The goal is to identify underlying drivers and tailor treatment. [1][2]
Can menopause cause dryness and painful sex? +
Yes. GSM can involve dryness, irritation, burning, and discomfort with sex, related to hormonal changes over time. Evidence-based options exist, including moisturizers, lubricants, and prescription therapies when appropriate. [3]
What if penetration is painful? +
Pain can have multiple causes (including vulvodynia, pelvic floor muscle tension/vaginismus, hormonal changes, infections, skin conditions). A careful evaluation helps determine the right plan, which may include pelvic floor therapy and pain-focused strategies. [4][5]
Are “vaginal rejuvenation” lasers FDA approved for sexual function claims? +
The FDA has issued warnings about marketing energy-based devices for “vaginal rejuvenation” claims and highlighted potential risks. We discuss device-based options carefully and focus on individualized, evidence-informed counseling. [7]
Do “bioidentical hormones” always help? +
Hormone therapy may help some symptoms for selected patients, but it’s not for everyone. Major societies caution against custom-compounded hormones unless medically necessary, and recommend evidence-based approaches with clear risk/benefit counseling. [3]
Credible Sources (Links)
- ACOG: Female sexual dysfunction overview (biopsychosocial causes and evaluation): https://www.acog.org/.../female-sexual-dysfunction
- ISSWSH: Patient resources and clinical approach to female sexual health (desire/arousal/pain): https://www.isswsh.org/patient-resources
- North American Menopause Society (NAMS): GSM information + hormone therapy / compounded hormone cautions: https://www.menopause.org/.../sexual-health-menopause-online
- Cleveland Clinic: Vulvodynia overview (symptoms, diagnosis, treatment): https://my.clevelandclinic.org/health/diseases/17878-vulvodynia
- Mayo Clinic: Vaginismus (symptoms and management overview): https://www.mayoclinic.org/.../syc-20354773
- Mayo Clinic: Pelvic organ prolapse overview: https://www.mayoclinic.org/.../syc-20360557
- FDA safety communication summarized by IUGA (energy-based devices marketed for “vaginal rejuvenation”): https://www.iuga.org/.../fda-safety-communication